Picardi, Antonio
Università Campus Bio-Medico · Campus Bio Medico University Hospital
4 papers on CoChatORCID 0000-0002-0230-218X
Most cited papers
- Verified
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Ratziu, V., de Guevara, L., Safadi, R., Poordad, F., Fuster, F., Flores-Figueroa, J., Arrese, M., Fracanzani, A. L., Ben Bashat, D., Lackner, K., et al. (2021) · Nature Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 222
- Verified
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores
De Vincentis, A., Tavaglione, F., Jamialahmadi, O., Picardi, A., Antonelli Incalzi, R., Valenti, L., Romeo, S., & Vespasiani-Gentilucci, U. (2022) · Clinical Gastroenterology and Hepatology
Liver Disease Diagnosis and TreatmentGenetic Associations and Epidemiology
Cited by 158
- Verified
Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-I treatment
Cemborain, A., Castilla-Cortázar, I., García, M., Quirog, J., Muguerza, B., Picardi, A., Santidrián, S., & Prieto, J. (1998) · Journal of Hepatology
Growth Hormone and Insulin-like Growth FactorsBone Metabolism and Diseases
Cited by 88
- Verified
Real-world experience with obeticholic acid in patients with primary biliary cholangitis
D’Amato, D., De Vincentis, A., Malinverno, F., Viganò, M., Alvaro, D., Pompili, M., Picciotto, A., Palitti, V. P., Russello, M., Storato, S., et al. (2021) · JHEP Reports
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 85
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free